Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke

SHU Jian-zhong; TANG Jun; LI Chen-yu; XUE Hong; LIU Jian-hui

doi:10.13422/j.cnki.syfjx.2016130177

您当前的位置：

首页 >

文章列表页 >

Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke

更新时间：2024-01-04

- Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 22, Issue 13, Pages: 177-181(2016)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2016130177
  CLC： R749.4;R743.3
- Published：2016
- 稿件说明：
移动端阅览
SHU Jian-zhong, TANG Jun, LI Chen-yu, et al. Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(13): 177-181.
DOI：

SHU Jian-zhong, TANG Jun, LI Chen-yu, et al. Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(13): 177-181. DOI： 10.13422/j.cnki.syfjx.2016130177.

摘要

目的: 探讨解郁安神颗粒合盐酸帕罗西汀片治疗缺血性脑中风后抑郁症的疗效以及对血清白细胞介素(IL)-6

IL-23

肿瘤坏死因子-α(TNF-α)

去甲肾上腺素(NE)和5-羟色胺(5-HT)水平的影响。方法: 筛选94例缺血性脑中风后抑郁症患者

按数字表法将所有病例随机分为观察组48例和对照组46例;两组患者根据《中国脑卒中康复治疗指南》给予常规治疗;对照组口服盐酸帕罗西汀片

初始剂量20 mg·d-1

每周以10 mg递增

最大剂量不超过40 mg·d-1。观察组在对照组治疗的基础上给予解郁安神颗粒

5 g/次

2次/d

冲服。两组患者均连续治疗6周。比较两组患者汉密尔顿抑郁(HAMD)量表评分

HAMD量表因子评分及临床疗效;检测两组患者血清IL-6

IL-23

TNF-α

NE和5-HT水平。结果: 观察组治疗后3周和6周HAMD量表评分分别低于对照组同时点(P < 0.01);观察组治疗后HAMD量表各因子评分明显低于对照组(P < 0.01);观察组的临床总有效率为91.67%

高于对照组的71.74%(P < 0.05);治疗后观察组血清IL-6

IL-23和TNF-α水平均低于对照组

NE和5-HT水平均高于对照组

比较差异有统计学意义(P < 0.01)。结论: 解郁安神颗粒合盐酸帕罗西汀片能提高缺血性脑中风后抑郁症的治疗

其治疗效果可能与下调患者血清IL-6

IL-23

TNF-α及上调NE

5-HT水平有关。

Abstract

Objective: To investigate the clinical efficacy of Jieyu Anshen particles combined with paroxetine hydrochloride tablets in treatment of depression after ischemic stroke its effects on levels of interleukin (IL)-6

IL-23

tumor necrosis factor-α(TNF-α)

norepinephrine (NE) and 5-hydroxytryptamine(5-HT) in serum. Method: Ninety-four patients with depression after ischemic stroke in our hospital were elected and randomly divided into observation group (48 cases) and control group (46 cases) according to random number table. All patients in both groups were treated with conventional intervention according to ‘Guidelines for Stroke Rehabilitation in China’. Patients in control group orally took paroxetine hydrochloride tablets

20 mg/day at beginning

increased by 10 mg per week

and with a maximum dose≤40 mg/day. Patients in observation group were given with Jieyu Anshen particles based on the treatment of control group

5 g/time

bid. Patients in both groups were treated for 6 weeks. Scores of Hamilton's depression scale (HAMD)

scores of HAMD factors

and clinical efficacy were compared between two groups. The levels of IL-6

IL-23

TNF-α

NE and 5-HT in serum were detected in both groups. Result: After 3 and 6 weeks' treatment

scores of HAMD scale in observation group were lower than those in control group (P < 0.01). Scores of HAMD factors in observation group were lower than those in control group after treatment (P < 0.01). The total effective rate was 91.67%in observation group

higher than 71.74%in control group (P < 0.05). After treatment

the levels of IL-6

IL-23

and TNF-α in serum of observation group were significantly lower

while NE and 5-HT levels were significantly higher than those of control group

with statistically significant differences (P < 0.01). Conclusion: Jieyu Anshen particles combined with hydrochloride tablets had definite efficacy in treatment of depression after ischemic stroke

and the therapeutic effect may be related with down-regulating the levels of IL-6

IL-23

TNF-α

and up-regulating NE and 5-HT levels in serum.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mahoniae Caulis Alkaloids Ameliorate Depression by Regulating Synaptic Plasticity via cAMP Pathway

Components and Brain-protective Effect of Chuanxiong Rhizoma-Paeoniae Radix Rubra in Improving Ischemic Stroke Based on UPLC-Q-TOF-MS

Characteristic Expression of Multiple Neurotransmitters Oscillation Imbabance in Brains of 1 028 Patients with Depression

Bupleuri Radix Associated Prescriptions Against Depression： A Review

Mechanism of Chinese Medicine in Promoting Angiogenesis After Ischemic Stroke Based on PI3K/Akt Signaling Pathway： A Review

Related Author

HE Junhui

JIA Chunlian

LAI Kedao

ZHOU Guili

ZHOU Rongfei

LI Yi

LI Dongmei

XIE Jiaxiu

Related Institution

Key Laboratory of Chemistry and Engineering of Forest Products， National Ethnic Affairs Commission， Guangxi Key Laboratory of Chemistry and Engineering of Forest Products/Guangxi Collaborative Innovation Center for Chemistry and Engineering of Forest Products， School of Chemistry and Chemical Engineering， Guangxi Minzu University

Guangxi Key Laboratory of Chinese Medicine Quality Standard， Guangxi Institute of Chinese Medicine and Pharmaceutical Science

Guangxi Medical University

Cancer Institute （Xuzhou） of Southeast University

Xuzhou Central Hospital

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰